DEXCOM INC Quarterly Deferred Federal Income Tax Expense (Benefit) in USD for Q4 2017
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.
-
Summary
-
Dexcom Inc annual/quarterly Deferred Federal Income Tax Expense (Benefit) history and growth rate for Q4 2017.
- Dexcom Inc Deferred Federal Income Tax Expense (Benefit) for the quarter ending December 31, 2017 was $0.000.
- Dexcom Inc annual Deferred Federal Income Tax Expense (Benefit) for 2023 was -$93.7K, a 97.8% increase from 2022.
- Dexcom Inc annual Deferred Federal Income Tax Expense (Benefit) for 2022 was -$4.3M, a 119% decline from 2021.
- Dexcom Inc annual Deferred Federal Income Tax Expense (Benefit) for 2021 was $23M.
Deferred Federal Income Tax Expense (Benefit), Quarterly (USD)